|This article needs additional citations for verification. (November 2009)|
|Classification and external resources|
Polyarteritis nodosa, also known as Panarteritis nodosa, Periarteritis nodosa,), Kussmaul disease or Kussmaul-Maier disease., is a vasculitis of medium and small-sized arteries, which become swollen and damaged from attack by rogue immune cells. Infantile polyarteritis nodosa is a type of PAN restricted to infants. In polyarteritis nodosa, small aneurysms are strung like the beads of a rosary, therefore making "rosary sign" an important diagnostic feature of the vasculitis.
With treatment, 5-year survival is 80%; without treatment, 5-year survival is 13%. Death is often a consequence of renal failure, myocardial infarction, or stroke.
Signs and symptoms
In this disease, symptoms result from ischemic damage to affected organs, often the skin, heart, kidneys, and nervous system.
Generalised symptoms include fever, fatigue, weakness, loss of appetite, and weight loss. Muscle and joint aches are common. The skin may show rashes, swelling, ulcers, and lumps. Palpable purpura and livedo reticularis can occur in some patients.
Nerve involvement may cause sensory changes with numbness, pain, burning, and weakness (peripheral neuropathy). Central nervous system involvement may cause strokes or seizures.
Kidney involvement can produce varying degrees of renal failure, such as hypertension, edema, oliguria and uremia.
Involvement of the arteries of the heart may cause a heart attack, heart failure, and inflammation of the sac around the heart (pericarditis).
- Abdominal pain
- Decreased appetite
- Unintentional weight loss
- Muscle aches
- Joint aches
- Stroke
- Kidney failure
- Heart attack
- Intestinal necrosis and perforation
Polyarteritis nodosa is a disease of unknown cause that affects arteries, the blood vessels that carry blood from the heart to organs and tissues. A minority of people (about 30%) diagnosed have an active Hepatitis B infection, and men are also twice as likely to get the disease as women.
There are no specific lab tests for diagnosing polyarteritis nodosa. Diagnosis is generally based on the physical examination and a few laboratory studies that help confirm the diagnosis:
- CBC (may demonstrate an elevated white blood count)
- ESR (elevated)
- Perinuclear pattern of antineutrophil cytoplasmic antibodies (p-ANCA) - not associated with "classic" polyarteritis nodosa, but is present in a form of the disease affecting smaller blood vessels, known as microscopic polyangiitis or leukocytoclastic angiitis.
- Tissue biopsy (reveals inflammation in small arteries, called arteritis)
- Elevated C-reactive protein
A patient is said to have polyarteritis nodosa if he or she has 3 of the 10 following signs known as the 1990 ACR (American College of Rheumatology) criteria:
- Weight loss greater than/equal to 4.5 kg.
- Livedo reticularis (a mottled purplish skin discoloration over the extremities or torso).
- Testicular pain or tenderness. (occasionally, a site biopsied for diagnosis).
- Muscle pain, weakness, or leg tenderness.
- Nerve disease (either single or multiple).
- Diastolic blood pressure greater than 90mmHg (high blood pressure).
- Elevated kidney blood tests (BUN greater than 40 mg/dl or creatinine greater than 1.5 mg/dl).
- Hepatitis B or Hepatitis C virus tests positive (for surface antigen or antibody).
- Arteriogram (angiogram) showing the arteries that are dilated (aneurysms) or constricted by the blood vessel inflammation.
- Biopsy of tissue showing the arteritis (typically inflamed arteries). Sural nerve is a frequent location for the biopsy.
It should be underlined that the 1990 ACR criteria were designed for classification purposes only. Nevertheless their good discriminatory performances, indicated by the initial ACR analysis, suggested their potential usefulness for diagnostic purposes also. Subsequent studies did not confirm their diagnostic utility, demonstrating a significant dependence of their discriminative abilities on the prevalence of the various vasculitides in the analyzed populations. Recently an original study, combining the analysis of more than 100 items used to describe patients characteristics in a large sample of vasculitides with a computer simulation technique designed to test the potential diagnostic utility of the various criteria, proposed a set of eight positively or negatively PAN discriminating items to be used as a screening tool for PAN diagnosis in patients suspected of systemic vasculitis.
Treatment involves medications to suppress the immune system, including prednisone and cyclophosphamide. In some cases methotrexate or leflunomide may be helpful. Some patients have also noticed a remission phase when a 4 dose infusion of rituximab is used before the leflunomide treatment is begun. Therapy results in remissions or cures in 90% of cases. Untreated, the disease is fatal in most cases. The most serious associated conditions generally involve the kidneys and gastrointestinal tract. A fatal course usually involves gastrointestinal hemorrhage, infection, myocardial infarction and/or renal failure.
The condition affects adults more frequently than children and males more frequently than females. Most cases occur between the ages of 30 and 49. It damages the tissues supplied by the affected arteries because they don't receive enough oxygen and nourishment without a proper blood supply.
- Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 1-4160-2999-0.
- synd/764 at Who Named It?
- Person, A, Donald (2006-06-15). "Infantile Polyarteritis Nodosa". eMedicine. WebMD. Retrieved 24 December 2009.
- Keen, William. Surgery, Volume 5. W. B. Saunders. p. 243.
- Greenson, Joel K.; Montgomery, Elizabeth A.; Polydorides, Alexandros D. (1 September 2009). Diagnostic Pathology: Gastrointestinal: Published by Amirsys. Lippincott Williams & Wilkins. ISBN 978-1-931884-26-6. Retrieved 19 August 2013.
- Russell Goodman, Paul F. Dellaripa, Amy Leigh Miller, and Joseph Loscalzo, (January 2, 2014). "An Unusual Case of Abdominal Pain". N Engl J Med 370 (1): 70–75. doi:10.1056/NEJMcps1215559.
- American College of Rheumatology
- Shiel, Jr., William C, http://www.medicinenet.com/polyarteritis_nodosa/article.htm
- Henegar, Corneliu; Pagnoux, Christian; Puéchal, Xavier; Zucker, Jean-Daniel; Bar-Hen, Avner; Guern, Véronique Le; Saba, Mona; Bagnères, Denis; Meyer, Olivier; Guillevin, Loïc (1 May 2008). "A paradigm of diagnostic criteria for polyarteritis nodosa: Analysis of a series of 949 patients with vasculitides". Arthritis & Rheumatism 58 (5): 1528–1538. doi:10.1002/art.23470. PMID 18438816.
- Boehm, Ingrid; Bauer, R (1 February 2000). "Low-Dose Methotrexate Controls a Severe Form of Polyarteritis Nodosa". Archives of Dermatology 136 (2): 167. doi:10.1001/archderm.136.2.167. PMID 10677090.
- Giannini, AJ; Black, HR. Psychiatric, Psychogenic and Somatopsychic Disorders Handbook. Garden City, NY. Medical Examination Publishing, 1978. Pp. 219–220. ISBN 0-87488-596-5
- Selga, D.; Mohammad, A.; Sturfelt, G.; Segelmark, M. (2006). "Polyarteritis nodosa when applying the Chapel Hill nomenclature--a descriptive study on ten patients". Rheumatology 45 (10): 1276–1281. doi:10.1093/rheumatology/kel091. PMID 16595516., Entry in Polyarteritis Nodosa Follow-up article
- Guillevin, L.; Lhote, F.; Cohen, P.; Sauvaget, F.; Jarrousse, B.; Lortholary, O.; Noël, L.; Trépo, C. (1995). "Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients". Medicine 74 (5): 238–253. doi:10.1097/00005792-199509000-00002. PMID 7565065. , Entry in Polyarteritis Nodosa Follow-up article
- Erhardt A, Sagir A, Guillevin L, Neuen-Jacob E, Häussinger D (October 2000). "Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine". J. Hepatol. 33 (4): 677–83. doi:10.1034/j.1600-0641.2000.033004677.x. PMID 11059878.